Advertisement
Advertisement

BRTX

BRTX logo

BioRestorative Therapies Inc

1.40
USD
-0.15
-9.68%
Dec 18, 15:59 UTC -5
Closed
...

BioRestorative Therapies Inc Profile

About

BioRestorative Therapies, Inc. develops therapeutic products and medical therapies using cell and tissue protocols, primarily involving adult stem cells. The company's core programs consist of Disc/Spine Program and Metabolic Program. Disc/Spine Program consists of cell therapy candidate, brtxDISC(TM) is a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow. Metabolic Program consists of ThermoStem(R), developing an allogeneic cell-based therapy to target obesity and metabolic disorders using brown adipose derived stem cells to generate brown adipose tissue. BioRestorative Therapies, Inc. is based in Melville, New York.

Info & Links

CEO

Lance Alstodt

Headquarters

40 MARCUS DRIVE, SUITE 1
MELVILLE, NY 11747, UNITED STATES

Industry

Medical Specialties

Sector

Health Technology

Website

www.biorestorative.com

Auditor

Marcum LLP

Share holders

352

Employees

11

BioRestorative Therapies Inc Statistics

Valuation Measures

Market Capitalization2

9.69M

Enterprise Value

8.24M

Enterprise Value/EBITDA(ttm)

-0.69

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

26.61

Price to Book(mrq)

1.01

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

96.23%

Operating Margin(ttm)

-3055.70%

Profit Margin(ttm)

-10998.11%

Return on Equity(ttm)

-98.49%

Return on Invested Capital(ttm)

-126.55%

Return on Assets(ttm)

-75.23%

Income Statement

Revenue(ttm)

377.00K

Revenue Per Share(ttm)

0.05

Gross Profit(ttm)

352.30K

EBITDA(ttm)3

-11.90M

Net Income Available to Common(ttm)

-13.65M

Diluted EPS(ttm)

-1.53

Share Statistics

Beta (5Y Monthly)

62.52

52-Week Change

-23.50%

S&P 500 52-Week Change

23.87%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

6.92M

Dividend Yield

0.00%

Float4

5.16M

% Held by Insiders

25.50%

% Held by Institutions

69.38%

Balance Sheet

Total Cash(mrq)

13.09M

Total Cash Per Share(mrq)

1.89

Total Debt(mrq)

42.40K

Total Debt/Equity(mrq)

0.42%

Current Ratio(mrq)

2.95%

Quick Ratio(mrq)

2.95%

Book Value Per Share(mrq)

1.44

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.72

Free Cash Flow(ytd)

-5.98M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement